6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Oorspronkelijke tekst

Deze vertaling beoordelen

Je feedback wordt gebruikt om Google Translate te verbeteren

Latest Press Releases

Time	Headline
Just now	Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors
Just now	TTM Technologies, Inc. Reports First Quarter 2026 Results
Just now	Meta Reports First Quarter 2026 Results
Just now	Codere Online to Release Financial Results for the First Quarter 2026 on May 7th
Just now	Smith Micro Reports First Quarter 2026 Financial Results

About

Biomark Diagnostics Inc (CN:BUX) — investor relations, events, news, and company updates on 6ix.

Latest News

BioMark Diagnostics to Present Liquid Biopsy Platform at the Canadian Thoracic Society Research Forum

BioMark Diagnostics Announces Publication of Peer-Reviewed Validation of Machine Learning Models for Lung Cancer Detection in Frontiers in Oncology

BioMark: 2025 Achievements & 2026 Vision

BioMark Diagnostics Announces Appointment of Mr. James Lavender to Board of Directors

BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program

Financials

Revenue

CA$91.77 K

Market Cap

CA$63.05 M

EPS

-0.02

Community Chat

Ask AI